Clinical trial
The Combined Role of FAPI PET and Liquid Biopsy in the Staging and Clinical Management of Bladder Cancer
NCT07257718 is registered in ClinicalTrials.gov with Chiti Arturo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Combined Role of FAPI PET and Liquid Biopsy in the Staging and Clinical Management of Bladder Cancer
- Lead sponsor
- Chiti Arturo
- Phase
- Phase 2
- Overall status
- Not yet recruiting
- Start date
- September 30, 2026
- Completion date
- September 30, 2031
- Enrollment
- 262 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
bladder cancer